Tirzepatide Weight Loss Treatment in Philadelphia, PA

Becoming a new patient is easy. Call our Philadelphia office 215-336-8000or complete our online contact form if you prefer not to call. You can also request a free telephone consultation with our Patient Care Coordinator to ask questions about services, pricing, and appointment availability.

Become a New Patient →

Dr. Fortino’s Philadelphia weight loss center is located on 1822 S. Broad St Philadelphia, PA 19145. Our South Philadelphia office is convenient to Fishtown, Center City, Northeast Philly, City Line Avenue, North Philadelphia and surrounding neighborhoods, the sports complex, and major highways. Dr. Fortino’s South Philadelphia office proudly serves patients throughout the city and surrounding counties, including: Philadelphia County, Montgomery County, Bucks County, Chester County, and Delaware County.

Interested in making an appointment with Dr. Fortino? Complete our contact form, and a member of our team will contact you.

Avoid Tirzepatide completely if your personal or family history includes Medullary Thyroid Carcinoma (MTC). If you have standard hypothyroidism or hyperthyroidism, schedule a clinical evaluation so our providers can safely determine your eligibility. Complete our online contact form, and a member of our team will contact you.

Tirzepatide treatment begins at 2.5 mg once weekly for the first four weeks. Starting with a lower dose allows the body time to adjust and may help reduce gastrointestinal side effects. After four weeks, the dose may be increased based on the patient’s response, tolerability, and individual medical needs.
If you’re searching for a trusted Tirzepatide weight loss doctor near you, Dr. Fortino offers expert care tailored to your success.

Yes, Tirzepatide changes how your body absorbs oral pills because it delays stomach emptying. Tell your doctor about all current prescriptions before starting treatment, especially oral contraceptives or medications that require precise, rapid absorption. Interested in learning more? Complete our contact form, and a member of our team will contact you.

At our clinic, we only treat adults who meet specific clinical criteria for Tirzepatide therapy. Adults qualify for chronic weight management if they meet established body mass index (BMI) thresholds:

• An elevated body mass index indicating obesity.
• An elevated body mass index indicating overweight, paired with at least one weight-related condition such as high blood pressure, high cholesterol, sleep apnea, or cardiovascular disease.

To ensure patient safety, a licensed healthcare professional must perform an in-person medical evaluation to verify these metrics and rule out key contraindications, including pregnancy or a personal or family history of medullary thyroid carcinoma. Disclaimer: This information is for general knowledge and should not be taken as medical advice. Consult with a healthcare provider to determine your clinical eligibility for any prescription medication.

Do not take tirzepatide if you are pregnant or planning to become pregnant. If you become pregnant while using this medication, stop taking it immediately and contact your healthcare provider to discuss safe alternative treatments. Before starting Tirzepatide weight loss treatment, Dr. Fortino reviews your medical history and current medications to determine whether treatment may be appropriate for you.

View FDA Prescribing Information for Zepbound (Tirzepatide)

You can achieve an average body-weight reduction of up to 20% over 72 weeks using tirzepatide, according to the landmark SURMOUNT-1 clinical trial. While individual results vary based on your personal health metrics, higher-dose groups in the study achieved the most substantial weight loss. You can review the peer-reviewed clinical trial data directly on PubMed.

When you stop taking tirzepatide, the medication gradually clears your system over a period of weeks. Natural appetite, hunger cues, and physiological responses related to appetite typically return as gastrointestinal motility and digestive processes adjust. Clinical data indicates that patients who discontinue treatment often experience weight regain over time. To support long-term metabolic health and manage treatment discontinuation, healthcare professionals develop personalized, physician-supervised strategies.

This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes.

While both are incretin-based medications, but they work differently. Semaglutide targets the GLP-1 receptor, while Tirzepatide targets both GIP and GLP-1 receptors. Which treatment may be appropriate depends on your medical history, goals, response, and other individual factors. Learn About Semaglutide Weight Loss Treatment →

Mounjaro® is an FDA-approved, once-weekly injectable prescription medication manufactured by Eli Lilly and Company. Its active pharmaceutical ingredient is tirzepatide, which represents a class of medications known as dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonists.

Approved Indications

• Glycemic Control: Indicated to improve blood sugar levels in adults with type 2 diabetes mellitus, as an adjunct to diet and exercise.
• Cardiovascular Risk Reduction: Indicated to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with type 2 diabetes mellitus who are at high risk for these events.

Note: Mounjaro® is not indicated or approved by the FDA as a medication for chronic weight management.

You can receive an in-person clinical evaluation to see if tirzepatide fits your weight-loss goals at the South Philadelphia medical clinic of Dr. Robert Fortino. Located at 1822 S. Broad Street, our clinic provides comprehensive medical consultations where Dr. Fortino reviews your health history, checks for contraindications, and analyzes your metabolic metrics. This face-to-face clinical assessment and follow up appointments ensures your plan is backed by continuous physician monitoring and ongoing care.

Ozempic® is a prescription, once-weekly subcutaneous injectable medication manufactured by Novo Nordisk. Its active pharmaceutical ingredient is semaglutide, which belongs to the class of medications known as glucagon-like peptide-1 (GLP-1) receptor agonists.

FDA-Approved Indications

The U.S. Food and Drug Administration (FDA) has approved Ozempic® for two specific clinical indications in adults:

1. Glycemic Control: To improve blood sugar levels in adults with type 2 diabetes mellitus, as an adjunct to diet and exercise.
2. Cardiovascular Risk Reduction: To reduce the risk of major adverse cardiovascular events (such as cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with type 2 diabetes mellitus and established cardiovascular disease.

Wegovy® is an FDA-approved, once-weekly injectable prescription medication containing the active ingredient semaglutide, a GLP-1 receptor agonist.

Approved Indications

• Chronic Weight Management: Indicated for adults with obesity (BMI ≥ 30 kg/m²), or overweight (BMI ≥ 27 kg/m²) alongside at least one weight-related condition (such as high blood pressure or high cholesterol), as an adjunct to a reduced-calorie diet and increased physical activity. It is also approved for pediatric patients aged 12 and older meeting specific BMI percentiles.
• Cardiovascular Risk Reduction: Approved to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal heart attack, or non-fatal stroke) in adults with established cardiovascular disease and obesity or overweight.

No. While Mounjaro® and Zepbound® share the same active pharmaceutical ingredient (tirzepatide), they are distinct, FDA-approved brand-name medications evaluated for separate clinical indications:

• Zepbound®: Indicated for chronic weight management in qualifying adults with obesity, or overweight accompanied by at least one weight-related condition (such as hypertension or dyslipidemia), as an adjunct to a reduced-calorie diet and increased physical activity.
• Mounjaro®: Indicated to improve glycemic control in adults with type 2 diabetes mellitus, as an adjunct to diet and exercise, as well as to reduce cardiovascular risk in certain adult populations with type 2 diabetes.

Because each medication is formulated and approved for distinct health conditions, prescribing decisions are based strictly on diagnostic criteria and medical history.

Yes, Dr. Robert Fortino offers physician-supervised Phentermine weight loss treatment at his South Philadelphia and Turnersville, NJ offices. As a short-term, oral appetite suppressant, Phentermine provides an effective non-injectable alternative for patients who prefer a daily pill over weekly GLP-1 injections. To ensure patient safety and meet strict BMI criteria, Dr. Fortino requires an initial in-person medical evaluation before any prescription is dispensed in-office. Throughout your treatment, our clinical team monitors your blood pressure and heart rate at every routine visit to track your physiological progress safely. Learn About Phentermine Weight Loss Treatment →

Interested in making an appointment with Dr. Fortino? Complete our online contact form, and a member of our team will contact you.

Yes, Dr. Robert Fortino provides physician-supervised Testosterone Replacement Therapy (TRT) and Low T treatment at his South Philadelphia clinic located at 1822 S. Broad Street. As a board-certified internal medicine physician who has treated men’s hormone health since 1999, Dr. Fortino requires an in-person clinical exam, a comprehensive medical history review, and formal morning blood testing before beginning any hormone treatment. If your diagnostic lab work confirms a clinical testosterone deficiency, he designs a personalized, injectable TRT protocol and conducts face-to-face follow-up visits to safely monitor your progress. Complete our online contact form, and a member of our team will contact you.

If you are looking for medical-grade, prescription MIC Lipotropic injections, you can receive physician-supervised treatment at either of Dr. Fortino’s offices. Genuine MIC (Methionine, Inositol, and Choline) fat-burning shots are classified as prescription-only formulations, meaning they require an in-person clinical evaluation rather than a commercial salon or unregulated online shop. Interested in MIC Lipotropic Injections? Complete our online contact form, and a member of our team will contact you.

Glutathione is a powerful antioxidant naturally produced by the body that helps protect cells from oxidative stress. It also supports the body’s normal detoxification processes and has been studied for potential effects on skin health and pigmentation, although evidence varies by formulation and method of administration. To learn more https://drfortino.net/glutathione-shot/

Dr. Robert Fortino provides prescription Vitamin B12 injections at his South Philadelphia medical office for patients requiring clinical nutrient support. These injections bypass digestive tract absorption barriers to support normal energy metabolism, promote proper red blood cell formation, and maintain healthy nervous system function. For individuals diagnosed with an underlying Vitamin B12 deficiency, Dr. Fortino utilizes these targeted injections to help manage and correct associated symptoms such as chronic fatigue and muscle weakness. If interested, complete our online contact form, and a member of our team will contact you.

Yes, Dr. Robert Fortino is accepting new patients at his South Philadelphia office. New patients can call 215-336-8000or complete the online contact form to get started. If you have questions before scheduling, you can also request a free telephone consultation with our Patient Care Coordinator.

While determining the single “best” physician is subjective, Dr. Robert Fortino holds an exceptionally high reputation and is widely recognized as a premier weight loss specialist in the region. Readers of The Philadelphia Inquirer officially voted his practice the 2026 Philly Favorites Gold Winner for Weight Loss Center. This first-place honor recognized his clinic at the top of a highly competitive category featuring the premier weight loss providers throughout the Greater Philadelphia region.

Multiple licensed healthcare providers prescribe Tirzepatide in Philadelphia. To ensure patient safety, Dr. Robert Fortino provides comprehensive, in-person evaluations and physician-supervised Tirzepatide treatment programs at his South Philadelphia office located at 1822 S. Broad Street. During your in person consultation, Dr. Fortino assesses your medical history and health metrics to determine clinical eligibility and customized ongoing follow-up care. Call 215-336-8000or complete our online contact form, and a member of our team will contact you.

Yes, you must have a medical prescription from a licensed healthcare provider to obtain Tirzepatide. To ensure your safety, Dr. Fortino requires a comprehensive, in-person clinical evaluation at his South Philadelphia office before approving your treatment. During this consultation, he reviews your health metrics to determine if Tirzepatide aligns with your unique wellness needs and weight loss goals. Once prescribed, Dr. Fortino actively supervises your treatment plan, providing continuous medical monitoring and routine follow-up care to guide your progress safely.